Standard heart failure treatments, such as diuretics, angiotensin-converting enzyme (ACE) inhibitors, and beta-blockers, are used; however, these therapies often have limited efficacy due to the unique pathophysiology of ATTR-wt, which includes reduced cardiac output and impaired myocardial relaxation [12]. Here, ACE is linked to heart failure.